Research programme: protein epitope mimetics cytokine inhibitors - Allergan/Polyphor
Latest Information Update: 06 Apr 2011
At a glance
- Originator Allergan; Polyphor
- Class Cyclic peptides
- Mechanism of Action Cytokine inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Eye disorders
Most Recent Events
- 06 Apr 2011 No development reported for Eye disorders in USA (Ophthalmic)
- 31 Oct 2008 Early research in Eye disorders in USA (Ophthalmic)